CM
NARI

Crestline Management’s Inari Medical, Inc. Common Stock NARI Stock Holding History

Crestline Management’s Portfolio NARI Stock Details NARI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-6,764
Closed -$345K – 705
2024
Q4 		$345K Buy
+6,764
New +$332K 0.01% 599
2022
Q1 		– Sell
-29,375
Closed -$2.68M – 339
2021
Q4 		$2.68M Sell
29,375
-3,823
-12% -$328K 0.2% 103
2021
Q3 		$2.69M Buy
+33,198
New +$2.79M 0.25% 88

Other funds holding NARI

SA
SoundView Advisors Olympia, Washington $281M AUM 17.96% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
TCWM
Total Clarity Wealth Management St. Charles, Illinois $515M AUM 27.37% 1-Year Est. Return
PS
Principal Securities Des Moines, Iowa $6.82B AUM 17.15% 1-Year Est. Return

Crestline Management's NARI Position: Q1 2025 in Review

Crestline Management sold out of Inari Medical, Inc. Common Stock (NARI) in Q1 2025, closing a stake of 6,764 shares — an estimated $345K sold.

Crestline Management first reported a position in NARI in Q3 2021 and held it in 3 quarters. The position peaked at $2.69M in Q3 2021. 4 funds tracked by Wall St. Rank hold NARI as of Q1 2025.

  • Crestline Management reported no remaining Inari Medical, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
  • Crestline Management sold 6,764 Inari Medical, Inc. Common Stock shares in Q1 2025, an estimated $345K.
  • Crestline Management first reported a position in Inari Medical, Inc. Common Stock in Q3 2021 and held it in 3 quarters.
  • Crestline Management's Inari Medical, Inc. Common Stock position peaked at $2.69M in Q3 2021.
  • 4 funds tracked by Wall St. Rank held Inari Medical, Inc. Common Stock as of Q1 2025.

Based on Crestline Management's 13F filing for Q1 2025, filed 15 May 2025.